At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Pilot Study of KeraStat® Cream for Radiation Dermatitis During Head and Neck Radiotherapy
In Brief
A clinical study evaluating KeraStat Cream and Routine Skin Care - Commercially Available Agents for Head and Neck Cancer and Radiation Dermatitis. Completed, enrolled 28 participants across 1 site.
Detailed Summary
This is a single site, randomized, open-label comparison pilot study to assess the feasibility and effectiveness of KeraStat Cream compared with routine skin care (RSC) in managing radiotherapy-induced early adverse skin reaction (EASR) in patients undergoing radiotherapy to the head and/or neck. Hypothesis: The use of KeraStat Cream in patients receiving radiotherapy for head and neck is feasible, tolerable, and reduces the severity of early adverse skin reaction in the treated region of interest.
Study Details
Timeline
Interventions
KeraStat Cream is a non-sterile, non-implantable, emollient-based wound dressing intended to act as a protective covering in the management of a variety of skin conditions.
Commercially available skin moisturizers from an approved list that do not interfere with radiation.